enoxacin has been researched along with Adenoma, Prostatic in 8 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enoxacin was administered at the daily dosage of 300 mg every 12 hours for 10 days." | 6.67 | [Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma]. ( Beghelli, R; Cortecchia, W; D'Amato, G; Dal Pra, ML; Emili, E; Frigola, M; Lo Cigno, M; Soli, M, 1991) |
| "Enoxacin was administered at the daily dosage of 300 mg every 12 hours for 10 days." | 2.67 | [Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma]. ( Beghelli, R; Cortecchia, W; D'Amato, G; Dal Pra, ML; Emili, E; Frigola, M; Lo Cigno, M; Soli, M, 1991) |
| "Enoxacin was administered orally at a dose of 200 mg, three times 2 days and one day before and once on the day of the operation." | 1.28 | [A study on enoxacin concentration in human prostatic tissue]. ( Kataumi, Z; Kitamura, Y; Nakamura, T; Takeda, H, 1990) |
| "Enoxacin is a new quinolone derivative that is well absorbed after oral administration and shows good efficacy against the pathogenic bacteria usually isolated in urinary infections." | 1.28 | In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man. ( Charton, M; Timbal, Y, 1990) |
| "Enoxacin was administered orally at a dose of 200 mg, three times one day before and twice on the day of operation." | 1.27 | [Enoxacin concentration in human prostatic tissue]. ( Asakawa, M; Kobayakawa, H; Yasumoto, R, 1986) |
| "Enoxacin was administered orally in a dose of 200 mg three times daily for 3 days preoperatively." | 1.27 | [Enoxacin concentration in human prostatic tissue after 3-day administration]. ( Hasuda, A; Kato, M; Kuji, S; Morita, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitamura, Y | 1 |
| Kataumi, Z | 1 |
| Nakamura, T | 1 |
| Takeda, H | 1 |
| Charton, M | 1 |
| Timbal, Y | 1 |
| Cortecchia, W | 1 |
| Beghelli, R | 1 |
| Frigola, M | 1 |
| Soli, M | 1 |
| Lo Cigno, M | 1 |
| Emili, E | 1 |
| D'Amato, G | 1 |
| Dal Pra, ML | 1 |
| Rannikko, S | 1 |
| Malmborg, AS | 1 |
| Yasumoto, R | 1 |
| Kobayakawa, H | 1 |
| Asakawa, M | 1 |
| Desai, KM | 1 |
| Abrams, PH | 1 |
| White, LO | 1 |
| Morita, M | 1 |
| Kato, M | 1 |
| Kuji, S | 1 |
| Hasuda, A | 1 |
| Naber, KG | 1 |
| Sörgel, F | 1 |
| Kees, F | 1 |
| Schumacher, H | 1 |
| Sigl, G | 1 |
| Zürcher, J | 1 |
| Berger, S | 1 |
2 trials available for enoxacin and Adenoma, Prostatic
| Article | Year |
|---|---|
[Enoxacin in the treatment of asymptomatic bacteriuria in patients with prostatic adenoma].
Topics: Aged; Bacteriuria; Drug Evaluation; Enoxacin; Humans; Male; Middle Aged; Prostatic Hyperplasia | 1991 |
A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Double-Blind Method; Enoxacin | 1988 |
6 other studies available for enoxacin and Adenoma, Prostatic
| Article | Year |
|---|---|
[A study on enoxacin concentration in human prostatic tissue].
Topics: Aged; Aged, 80 and over; Enoxacin; Humans; Male; Middle Aged; Premedication; Prostate; Prostatic Hyp | 1990 |
In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
Topics: Aged; Chromatography, High Pressure Liquid; Enoxacin; Humans; Kidney; Male; Middle Aged; Nephrectomy | 1990 |
Enoxacin concentration in human prostatic tissue after oral administration.
Topics: Administration, Oral; Enoxacin; Humans; Male; Naphthyridines; Prostate; Prostatic Hyperplasia | 1986 |
[Enoxacin concentration in human prostatic tissue].
Topics: Administration, Oral; Anti-Infective Agents; Enoxacin; Humans; Male; Naphthyridines; Prostate; Prost | 1986 |
[Enoxacin concentration in human prostatic tissue after 3-day administration].
Topics: Administration, Oral; Aged; Anti-Infective Agents, Urinary; Drug Administration Schedule; Enoxacin; | 1988 |
[Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
Topics: Administration, Oral; Adult; Aged; Body Fluids; Enoxacin; Humans; Infusions, Intravenous; Male; Midd | 1989 |